CURRICULUM VITAE
Sailaja Kamaraju MD
Sailaja Kamaraju MD
Associate Professor
Department of Medicine
Division of Hematology and Oncology - Medicine
Career Path-Clinician Educator Track
Department of Medicine
Division of Hematology and Oncology - Medicine
Career Path-Clinician Educator Track
OFFICE ADDRESS: |
Clinical Cancer Center |
9200 W Wisconsin Ave |
Milwaukee, WI 53226 |
Email: skamaraju@mcw.edu |
EDUCATION: |
09/1986 - 05/1992 MB & BS, Nagarjuna University / Guntur Medical College, Guntur, India |
08/2012 - 05/2015 MSCR, Medical College of Wisconsin, Milwaukee, WI |
09/2015 - 06/2017 CRSP, Medical College of Wisconsin, Milwaukee, WI |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
01/01/1993 - 12/31/1995 Clerkship, Hematopathology, University of Texas Health Sciences, Houston, TX |
01/01/1995 - 01/01/1996 Internship, Medical Education Program (THMEP), Tucson Hospitals, Tucson, AZ |
01/01/1996 - 05/31/1999 Internal Medicine Residency, Hennepin County Medical Center, University of Minnesota, Minneapolis, MN |
06/01/1999 - 12/31/2002 Fellowship, Hematology & Oncology, University of Minnesota, Minneapolis, MN |
01/01/2000 - 12/31/2002 Breast Cancer Basic Research, University of Minnesota, Minneapolis, MN |
FACULTY APPOINTMENTS: |
01/2003 - 12/2011 Medical Oncologist, Aurora Lakeland Cancer Center, Elkhorn, WI., Aurora Women's Pavilion and Aurora Summit Cancer Center, Oconomowoc, WI., West Allis and Oconomowoc., WI |
01/2012 - 07/2018 Assistant Professor, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI |
07/2018 - Present Associate Professor, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
01/2003 - 12/2006 Medical Director, Vince Lombardi Cancer Clinic, Aurora Lakeland Medical Center, Elkhorn, WI |
01/2006 - 12/2011 Medical Director, Vince Lombardi Cancer Center, Aurora Wilkinson Medical Clinic, Oconomowoc, WI |
10/2013 - 10/2020 Medical Director, Cancer Center at Froedtert Moorland Reserve Health Center, New Berlin, WI |
HOSPITAL STAFF PRIVILEGES: |
11/2013 - Present Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Ave., Milwaukee, WI 53226 |
11/2016 - Present Community Memorial Hospital, W180 N8085 Town Hall Road, Menomonee Falls, WI |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
Internal Medicine | 10/2009 | 10/2016 |
Medical Oncology | 11/2014 | 12/2024 |
Licensure | Number | Issue Date | Expiration |
DEA | FK1065729 | 02/2002 | 12/31/2023 |
Wisconsin License | 44909-20 | 02/2002 | 10/31/2025 |
AWARDS AND HONORS: |
01/1984 Medical Student Award, Indian Council of Medical Research, Guntur Medical College, Guntur, AP, India |
01/1986 Best Biology Student, Class of 1986, Nagarjuna University / Guntur Medical College, Guntur, AP, India |
01/1998 Maximum Number of Walk-In Patients Award (Clinic Resident), Hennepin County Medical Center, Minneapolis, MN. |
01/1999 Best Resident Award, Resident Research Committee, Hennepin County Medical Center, Minneapolis, MN. |
01/1999 Best Resident Award for Teaching (Internal Medicine Residency), Hennepin County Medical Center, Minneapolis, MN. |
09/2010 Aurora Star Award (for Compassionate Care), Aurora Women's Pavilion, West AllIS, WI. |
05/2015 Champions in Women's Health, a Wisconsin Women's Foundation award, Presented by Ms. Sue Ann Thompson. This award was given in recognition of community outreach for cancer prevention among minority women in Wisconsin. |
07/2016 Community Volunteer Physician Award, Muslim Community Health Center, 803 Layton Avenue, Milwaukee, WI. |
09/2019 MCW Cancer Center Award, MCW for Cancer Disparities research |
05/2021 MCW Faculty Vitality Award, ASCO Cancer Disparities Research, Medical College of Wisconsin |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
01/1995 - Present Indian Medical Association |
01/2002 - 12/2006 American Society of Hematology |
01/2002 - Present American Society of Clinical Oncology (ASCO) |
06/2015 - Present ASCO Conquer Cancer Foundation Donor Group / Conquerors Circle |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Journal Review |
01/2007 - Present Clinical Breast Cancer Journal |
05/2018 - Present CANCER, A High Impact Cancer Journal |
09/2018 - Present Cancer Research and Treatment, A High Impact Journal |
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
02/2003 - 11/2011 Member, Breast Cancer Committees, Aurora Health Care System |
06/2006 - 11/2011 Member, Patient Advisory Committee, VLCC, Oconomowoc |
06/2006 - 06/2021 Member, Aurora Health Care Logic, Cancer Initiative Program |
06/2007 - 11/2011 Member, Summit Cancer Center Quality Improvement Program |
06/2007 - 11/2009 Member, Patient-Centered Care Delivery, Aurora System Cancer Program |
10/2007 - Present Founder, Cancer Awareness Camps & Events for Asian Communities Organizer, Community Cancer Awareness and Survivorship Events |
01/2012 - Present Member, Breast Cancer Research Committee, Froedtert & MCW |
01/2012 - 10/2013 Member, Survivorship Committee, Kraemer Cancer Center, St. Joseph's Hospital, West Bend, WI |
10/2012 - Present Member, Center for Advancing Population Sciences (CAPS), MCW |
12/2012 - 01/2013 Member, Review Committee, Susan G. Komen Foundation |
10/2014 - 2018 Member, Cancer Center Community Advisory Board / Cancer Prevention Group, Survivorship Group |
09/2016 - Present Committee Member, Scientific Review Committee (SRC)-Serving as the Committee Member for the third term., SRC, MCW |
04/2018 - Present Chair and Founder, Cancer Disparities Symposium, MCW |
01/2020 - Present Co-chair, WAHO Annual San Antonio Breast Cancer Symposium, Highlights meeting held annually on the last Saturday of January., WAHO |
12/2020 - Present Executive Board Member, Wisconsin Association of Hematology-Oncology (WAHO) |
12/2024 - 12/2026 Secretary, Executive board, Wisconsin Association of Hematology-Oncology (WAHO0 |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
05/2019 - Present Member, Alliance Foundation, Cancer in Older Adults Committee |
05/2019 - Present Member, Alliance Foundation, Disparities Committee |
10/2019 - Present Member, Cancer and Aging Research Group (CARG) |
12/2020 - Present Executive Board Member, Wisconsin Association of Hematology-Oncology |
01/2023 - Present Chair, Alliance Disparities Clinical Trial Enrollment Subcommittee |
INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
06/01/2017 - 06/01/2019 Member, ASCO Prevention Committee, ASCO |
04/01/2019 - 04/01/2023 Member, Health Equity Committee, ASCO |
02/01/2020 - 02/01/2021 Member, Cancer Prevention: Genetics Subcommittee, ASCO |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
National |
Are Aromatase Inhibitors Associated with Higher Myocardial Infarction Risk in Breast Cancer Patients? A Medicare Population Study., Oral Presentation and Poster Discussion,, San Antonio Breast Cancer Symposium, Program Number PD4-07, San Antonio, TX, 12/08/2016 |
Cancer Network Media Presentation, San Antonio Breast Cancer Symposium, Oral Presentation and Press Release, San Antonio Breast Cancer Symposium, San Antonio, TX, 12/08/2016 |
Co-chair, WAHO Annual San Antonio Breast Cancer Symposium Highlights meeting, San Antonio, TX, 01/2020 - Present |
Kamaraju, Sailaja (Team Leader & Coordinator of Oral Presentation), Niarchos – Quality Training Grant, ASCO QI, Alexandria, VA., 06/02/2020 |
Cancer Prevention in Low Resource Countries: An Overview of the Opportunity, ASCO Educational Symposium, ASCO Virtual Annual Meeting, Chicago, IL, 08/06/2020 |
Diversity and Inclusion in Clinical Trials, Cancer Disparities Symposium, Panel Speaker, National Symposium sponsored by Novartis Pharmaceuticals, Virtual, 09/17/2020 |
Niarchos – Quality Improvement Grant Addressing Cancer Disparities, Oral & Virtual Presentation, ASCO, 09/24/2020 |
Learning Collaborative Session on Examining the Social Determinants of Health to Address Inpatient Length of Stay for Oncology Patients, Oral & Virtual Presentation to Niarchos – Quality Improvement Grantees, ASCO, 07/06/2021 |
The SMILE Study- Oral antiprogestin, onapristone in combination with fulvestrant for metastatic ER+/HER2- breast cancer, oral presentations on IIT update, Wisconsin Oncology Network (WON), 09/24/2022 |
Kamaraju Sailaja, Powell Miracle, ASCO QI-QTP Project presentation, 12/15/2022 |
Final ASCO QI-QTP Project presentation with the projects’ results for all these three years Niarchos QI-QTP projects from 2019-2023, ASCO, ASCO, 05/18/2023 |
Disparities in cancer care for older adults, Fourth Annual Cancer Disparities Symposium, 09/29/2023 |
Kamaraju, Sailaja, Minority Trial Enrollment: Alliance Clinical Trial Session, Alliance for Clinical Trials in Oncology Fall 2023 Hybrid Group Meeting, 11/03/2023 |
Inequities related to biological and social determinants of health: An update from SABCS, 2/3/2024., SABCS- WAHO:, Italian Community Center, 02/03/2024 - Present |
ASCO Taskforce projects' highlights, Virtual, Nationwide Virtual, 03/20/2024 - Present |
Kamaraju, Sailaja, Alliance Disparities Committee Working Monthly Minority Outreach and Accrual Updates, Completed in the years of 5/5/23, 8/22/23, 11/3/23, 1/23/24, 2/2/24, 4/2/24, 5/17/24 |
Regional |
Cardiotoxicity of Cancer Treatment: An Update in Hematological and Oncological Malignancies, Green Bay, WI, 10/06/2012 |
Cardiotoxicity of Cancer Treatment from An Oncologist’s Perspective, American College of Physicians (ACP), Cardiology State Chapter, Kohler, WI, 05/2013 |
Caring for the Cancer Survivor – All We Need to Know, Presentation at 44th Annual Winter Refresher Course for Family Medicine, Pewaukee, WI, 02/06/2014 |
Cancer Myths and the Facts, Presentation for Southeastern Oneida Tribal Office in Collaboration with WI Pink Shawl, 03/24/2018 |
Cardiotoxicity of Cancer Treatments, Oral Presentation, St. Vincent Hospital, Green Bay, WI, 04/20/2018 |
Oral Antiprogestin, Onapristone in Combination with Fulvestrant for Metastatic ER+/HER2 – Breast Cancer, Oral Presentations on IIT Concept Presentation, Wisconsin Oncology Network (WON), UW Madison, WI, 08/2019 |
After Breast Cancer Diagnosis, Panel Speaker for Healthcare Providers Continuing Education Program, ABCD.ORG, Virtual presentation, 10/26/2020 |
An Update on Brain Metastasis and Management in Breast Cancer, Wisconsin Association of Hematology-Oncology (WAHO), Symposium, WAHO Symposium, 01/29/2022 |
Evaluating Treatment Landscape for MHR+ breast Cancer: how to personalize care and improve patient outcomes, Session moderator, WON, 10/12/2023 |
A phase 2 trial of onapristone and fulvestrant for HR+/HER2- metastatic breast cancer:Study updates., Wisconsin Association of Hematology and Oncology and Wisconsin Oncology Network (WAHO-WON)., MADISON, WI, 09/21/2024 - Present |
Local |
Community Engagement Seminar & Oral Presentation at Our City of Nations, Supporting Refugees and Recent Immigrants (OCON) Conference, Milwaukee, WI, 12/04/2015 |
Debunking the Cancer Myths, Four-part Speaker Series offering engaging and interactive glimpse into the world of human health and disease and exploring groundbreaking changes taking place in biomedical research, medical education, and patient care, Conversations with Scientists: Oral Presentation, MCW, Milwaukee, WI, 04/20/2016 |
Cancer Myths and the Facts, Presentation for Summer Interns, MCW, Milwaukee, WI, 06/20/2017 |
Cancer Survivorship, Oral Presentation at Southeast Wisconsin Cancer Conference, Italian Community Center, Milwaukee, 03/17/2018 |
Oral Antiprogestin, Onapristone in Combination with Fulvestrant for Metastatic ER+/HER2 – Breast Cancer, Oral Presentations on IIT Concept Presentation, The SMILE Study, Wisconsin Oncology Network (WON), Hilton hotel, Milwaukee, 08/08/2020 |
Social determinants vs. biological determinants of cancer care: Addressing Barriers at the
Grassroots, Grand Rounds, MCW, 04/07/2023 |
PEER REVIEWED WORKSHOPS/PRESENTATIONS: |
National |
International Society of Infectious Diseases: Pulmonary Valve Endocarditis in a Dialysis Patient, Poster Presentation at International Society of Infectious Diseases Annual Meeting, Denver, CO, 11/1998 |
Case Report of Staphylococcus lugdunensis Pulmonary Valve Endocarditis and Literature Review, Poster Presentation at Annual Meeting of American College of Physicians, New Orleans, LA, 04/1999 |
McDowell BD, Klemp J, Blaes An, Cohee, AA, Dietz AT, Kamaraju S, Otte JL, Rock JL, Rubenstein L, Chrischilles EA, ‘Survivorship Care Planning is Associated with Breast Cancer Survivors’ Reported Quality and Coordination of Care, Program Number PD4-05, Poster Presentation at San Antonio Breast Cancer Symposium, San Antonio, TX, 12/08/2016 |
Cancer Prevention in Low Resource Countries: An Overview of the Opportunity, ASCO Educational Symposium, ASCO Annual Meeting, Chicago, IL, 05/2020 |
WAHO-Annual San Antonio Breast Cancer Symposium’s Highlights meeting presentation, 01/30/2021 |
American Cancer Society countrywide grantees nationwide learning collaborative/grand rounds, Virtual presentation for 30 minutes, 03/20/2024 |
Co-chair, moderator and speaker, WAHO-Annual San Antonio Breast Cancer Symposium’s Highlights meeting presentation, 01/30/2021- Co-moderator and a speaker: Survivorship: An Update from SABCS.
01/29/2022 Co-moderator and a speaker of CNS metastases: An update from SABCS
01/28/2023- Co-moderator
02/03/2024- Co-moderator and a speaker on Inequities related to biological and social determinants of health: An update from SABCS. |
Cancer Disparities – Clinical Trial Subcommittee Chair- The Alliance Foundation for Clinical Trials, Oral presentations: 11/3/23, 5/17/2024 and presentations at monthly updates. |
Regional |
Ischemic Stroke – A Complication of Essential Thrombocythemia – Role of Ticlopidine, Poster Presentation at American College of Physicians, Minnesota State Chapter, Minneapolis, MN, 11/1997 |
IGF (insulin-like growth factor) Induced Stimulation of Insulin Receptor Substrate (IRS- 2) Enhances Cell Migration and Proliferation in MCF-7L/ATCC Cell Lines, Poster Presentation at American Society of Endocrinology Annual Meeting, Denver, CO, 06/2001 |
mHealth Intervention to Address Cancer Disparities Among Breast Cancer Patients with Low Health Literacy: A Feasibility Pilot Study for Patients on Active Chemotherapy and their Companions / Caregivers, Oral Presentation, Alliance Foundation, Lowes, Chicago, IL, 11/07/2019 |
African American Breast Cancer Survivor group, Online seminars. Participated as a speaker on cancer survivorship, 6-8 African American cancer survivors per session participated in this event,, 05/18/2021 |
Multiple local seminars at Susan G. Komen Foundation Walk for Cure events and local churches (9/2020, 6/2018, 7/2022) |
Local |
Promoting Breast Health Education among Asian Women, Poster Presentation at MCW Community Engagement Week, MCW, Milwaukee, WI, 04/18/2016 - 04/22/2016 |
Speaker at a Latina Breast Cancer Survivor group events, Core El Centro, Milwaukee, 10/31/2020 |
African American Breast Cancer Survivor group: Online seminars. Participated as a speaker on cancer survivorship, 6-8 African American cancer survivors per session participated in this event., 11/03/2020 |
Cancer Awareness workshop: Founder and moderator, Virtual, Hindu Temple of Wisconsin, 10/02/2021 |
COMMITTEE SERVICE: |
Hospital |
01/2002 - 01/2014 Volunteer, Satya Sai Spiritual Center |
01/2007 - Present Founder, Annual Women’s Health Day Seminars (breast cancer education, cancer prevention, cultural model development for awareness in minority and refugee women) |
01/2007 - Present Participant, Komen Race for the Cure |
01/2007 - 10/2011 Volunteer, Breast Cancer Awareness: What You Need to Know Seminars for Asian Women |
01/2009 - 01/2012 Speaker & Volunteer, Breast Cancer Conferences & Residential Seminars, Guntur Medical College / Ananthapur Medical College, India Mobile Medical Camps |
01/2010 - 02/2012 Volunteer, Breast Cancer Awareness Pink Hair Extension Community Project, West Allis Memorial Hospital |
2018 - Present Founder and Chair, Cancer Disparities Symposium held annually in September |
01/04/2023 Health Disparities Committee’s Co-chair, A011801 clinical trial |
02/02/2023 Chair of the outreach and accrual working group, Alliance Disparities Committee |
MCW TEACHING ACTIVITIES: |
Resident and Fellow Education |
11/13/2024 An Update on Breast Cancer Treatment for Internal Medicine Residents |
EXTRAMURAL TEACHING: |
Medical Student Education |
12/04/2015 Our City of Nations (OCON) Supporting Refugees and Recent Immigrants Conference, Medical Student Lecture |
06/2016 - 06/2017 Cancer Myths & Facts, Lecture to Summer Interns |
06/12/2018 - 06/2020 Breast Cancer from Diagnosis to Survivorship, Lecture to Summer Interns |
Graduate Student Education |
05/2002 - 08/2002 Marquette University, Medical Ethics Course |
Resident and Fellow Education |
08/10/2012 - Present Kraemer Cancer Center, West Bend, WI, Models of Survivorship – Presentation |
10/19/2012 Department of Medicine, Internal Medicine Residents Lecture Series, Toxicities of Cancer Treatment |
03/20/2015 Breast Cancer Lecture Series for Fellows, Adjuvant Breast Cancer Therapy |
03/20/2015 Breast Oncology Fellows’ monthly breast oncology group meetings, Monthly Breast Cancer Journal Update |
04/01/2016 Toxicities of Cancer Treatment and Survivorship, Lecture for Fellows |
04/06/2018 Novel Treatments for Metastatic Estrogen Receptor Positive HER2 Negative Breast Cancer, Lecture for Fellows |
10/23/2018 Lecture for nurses at Froedtert and affiliated hospitals, Cancer Survivorship for Breast Cancer Patients (CME Lecture) |
12/11/2023 Dissertation Committee Member for Aigbe Ohihoin (post doc candidate) qualifying oral exam and presentation |
Continuing Medical Education |
09/2004 - 05/2005 UW-Milwaukee, Medical Terminology in the EMR |
04/05/2012 Medical Oncology Section Meeting, Challenges and Models of Survivorship |
2012 - Present Faculty Research Committee |
2012 - Present Weekly Breast Cancer Tumor Board (part of breast cancer service line) |
2012 - Present Monthly Breast Medical Oncology Faculty Group |
Community/Lay Public |
01/1989 - Present Over the past two decades, I have given nearly 50 talks in local faith-based centers on cancer education, covering screening guidelines, chemotherapy, and survivorship. This experience ignited my passion for addressing cancer disparities, community engagement, and outreach. |
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Medical Students |
07/2021 - 07/2022 Miracle Powell, BS, Research Coordinator, Medical College of Wisconsin, Presented multiple abstracts at ASCO, ACP and SABCS, their publications are in progress. |
10/2021 - Present Heun Lin, BS (M3), Capacity Pathway Advisor, Medical College of Wisconsin |
10/2021 - Present Alexandra Harris, BS (M3), Student Mentor / Research Mentor, Medical College of Wisconsin |
10/2021 - Present Meghan Conroy, BS (M3), Student Mentor / Research Mentor, Medical College of Wisconsin |
05/2024 - Present Yetunde Ogunsesan, Collaborating with me on breast cancer and disparities projects., Medical College of Wisconsin |
Clinical Staff |
Kelsey Micech, APNP, Drexel Townsquare Cancer Center (training)
Sarah Ramirez, PA-C, Drexel Townsquare Cancer Center (training)
Angela Halbach, APNP, Froedtert & MCW Breast Clinic, Clinical Cancer Center
Jutta Deininger, WHNP, Froedtert & MCW Breast Clinic, Clinical Cancer Center
Mary Beth Holden, PA-C, Moorland Reserve Cancer Center (training), training, Medical College of Wisconsin |
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Residents |
Emmanuel Tavares (M3) (Global Health Pathway), Currently a PGY-3 General Surgery Resident at UC Davis, California, Co-Author, WMJ, 7/2018, Poster Presentation at the MCW Community Engagement Week, 04/18/2016-04/22/2016, Co-Author, WMJ, 7/2018 |
Amrita Rao (M3) (Global Health Pathway), Completed Family Medicine residency at UC Davis, California, practicing at U.S. Public Health Services, Indian Hospital in Sacramento, CA, Co-Author, WMJ, 2019 |
Community Health Workers and Navigators, Trained a total of 30-40 CHWs and navigators through the Susan G. Komen Foundation grant (2014-2018) and AHW (2021-2023) |
Kate Krause (M4) (Urban and Community Health Pathway), Currently a PGY-3 General Surgery Resident at Massachusetts General Hospital, 7/2018, Oral Presentation at MCW Research Day (03/18/2016), Co-Author, WMJ, 7/2018 |
COMMUNITY SERVICE ACTIVITIES: |
08/01/2003 - 07/23/2024 I have been very actively involved in community service. Over the years, I volunteered at the Homeless Women's Shelter and multiple faith-based centers in Milwaukee. I also gave several talks to African American and Hispanic cancer survivor groups. As shown in my bibliography, several of these manuscripts have been published. |
FUNDS RAISED FOR CANCER DISPARITIES SYMPOSIUM: |
09/08/2019 Chair and Founder of the Cancer Disparities Symposium at MCW.
Title: First Annual Cancer Disparities Symposium: A Focus on the Burden of Triple Negative Breast Cancer; Funds Raised: $45,000
|
09/07/2020 Title: Second Annual Cancer Disparities Symposium: A Focus on the Burden of Prostate Cancer Dates: 09/07/2020 Funds Raised: $22,500 |
09/24/2021 Title: Third Annual Cancer Disparities Symposium: A Focus on the Cancer Disparities Among Sexual and Gender Minorities; Funds Raised: $25,000 |
09/29/2023 Title: Fourth Annual Cancer Disparities Symposium: A Focus on the Cancer Disparities Among Older adults Funds Raised: $30,000 |
TRAVEL GRANTS: |
02/26/2019 Agendia – Mammaprint FLEX Database Registry Retreat |
10/19/2019 Pfizer Travel Grant – ER+ Breast Cancer Retreat |
Alliance Health Equity Committee Travel Grant (08/2018, 09/2019 & 5/2024)
|
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Kamaraju S, Nelson K, Williams DN, Ayenew W, Modi KS. Staphylococcus lugdunensis pulmonary valve endocarditis in a patient on chronic hemodialysis. Am J Nephrol. 1999;19(5):605-8. |
2. Zhang X, Kamaraju S, Hakuno F, Kabuta T, Takahashi S, Sachdev D, Yee D. Motility response to insulin-like growth factor-I (IGF-I) in MCF-7 cells is associated with IRS-2 activation and integrin expression. Breast Cancer Res Treat. 2004 Jan;83(2):161-70. |
3. Neuner JM, Kamaraju S, Charlson JA, Wozniak EM, Smith EC, Biggers A, Smallwood AJ, Laud PW, Pezzin LE. The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees. J Natl Cancer Inst. 2015 Aug;107(8). PMCID: PMC4580559 |
4. Kamaraju S, Depke J, Povletich J, Currey A, Weil E. Cutaneous Metastasis due to Breast Cancer in a Patient with Primary Biliary Cirrhosis: A Case Report. Case Rep Oncol. 2016;9(3):718-725. PMCID: PMC5126598 |
5. Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA. Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. J Cancer Surviv. 2018 Apr;12(2):268-275. |
6. Chaudhary LN, Jawa Z, Hanif A, Szabo A, Kamaraju S, Cheng YC, Chitambar CR. Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ? WMJ. 2018 Jun;117(2):62-67. |
7. Kamaraju S, DeNomie M, Visotcky A, Banerjee A, Krause K, Tavares E, Rao A, Drew E, Neuner J, Stolley M. Increasing Mammography Uptake Through Academic-Community Partnerships Targeting Immigrant and Refugee Communities in Milwaukee. WMJ. 2018 Jun;117(2):55-61. |
8. *Hunley J, Kamaraju S, Holder P, Szabo A, Burlingame-Toppen R, Stolley M. The effect of yoga on barriers to occupational engagement in African American breast cancer survivors Cancer Medicine Journal. Med J 2018: 1(1) 3-11. Although the second author, I contributed significantly to this project with data analysis and manuscript writing. |
9. Kamaraju S, Shi Y, Smith E, Nattinger AB, Laud P, Neuner J. Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population-based study. Clin Cardiol. 2019 Jan;42(1):93-100. PMCID: PMC6344290 |
10. Kamaraju K, Jacquart A, Stachowiak S, Geurts J, Deepas M, Olson J, Chaudhary L, Chitambar C, Neuner J, YeeCheng YC.
Disparities in genetic referrals for breast cancer among the Asian immigrant populations: How can we eliminate them? Annals of Public Health Reports. |
11. McDowell BD, Klemp J, Blaes A, Cohee AA, Trentham-Dietz A, Kamaraju S, Otte JL, Mott SL, Chrischilles EA. The association between cancer care coordination and quality of life is stronger for breast cancer patients with lower health literacy: A Greater Plains Collaborative study. Support Care Cancer. 2020 Feb;28(2):887-895. PMCID: PMC6893112 |
12. *Lightfoot C, Oxencis C, Weil E, Urmanksi A, Amundson B, Rein L, Kamaraju S. Effect of HER2 receptor expression on cardiac ejection fraction in cancer patients treated with trastuzumab. Open Journal of Cardiology and Heart Diseases. DOI: 10.31031/OJCHD.2019.03.000554. I supervised the first author, a pharmacy resident, during this project. |
13. Kamaraju S, Drope J, Sankaranarayanan R, Shastri S. Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity. Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-12. PMCID: PMC7935443 |
14. Ernst A, Flynn KE, Weil EM, Crotty BH, Kamaraju S, Fergestrom N, Neuner J. Aromatase Inhibitor Symptom Management Practices: A Retrospective Study. Clin Breast Cancer. 2021 Feb;21(1):e38-e47. PMCID: PMC8923736 |
15. Kamaraju S, Fowler AM, Weil E, Wisinski KB, Truong TH, Lehr M, Chaudhary LN, Cheng YC, Chitambar CR, Rui H, Yee D, Lange C. Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. Endocrinology. 2021 Aug 01;162(8). |
16. Kamaraju S, Mohan M, Zaharova S, Wallace B, McGraw J, Lokken J, Tierney J, Weil E, Fatunde O, Brown SA. Interactions between cardiology and oncology drugs in precision cardio-oncology. Clin Sci (Lond). 2021 Jun 11;135(11):1333-1351. PMCID: PMC8984624 |
17. Kamaraju S, Merrill J, Wu J, Jeames S, Conroy M, Min H, Powell M, Padela, A. Patient Navigation Based Care-delivery to Reduce Inequities in Cancer Care Among Immigrants and Refugees: A Commentary on the Successes and the Unmet Needs. International Journal of Cancer Care Delivery International Journal of Cancer Care Delivery. |
18. Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE. Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence. J Am Pharm Assoc (2003). 2022;62(4):1321-1328.e3. |
19. Sridhar N, Glisch C, Jawa Z, Chaudhary LN, Kamaraju S, Burfeind J, Charlson J, Chitambar CR, Jorns JM, Cheng YC. Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study. J Cancer. 2022;13(8):2472-2476. PMCID: PMC9174868 |
20. Kamaraju S, Canales B, Wright T, Charlson J, Wetzel T, Cadman J, Szabo A, Williams J, Power S, Campbell G. . Patient Specific Factors Associated with Inpatient Hospital Length of Stay for Solid Tumor Oncology Patients: a retrospective cohort study Annals of Cancer Epidemiology, 2022;6:-5. . |
21. Kamaraju T, Atkinson D, Wright T, Charlosn J, Wetzel T, Campbell G, Cadman J, Williams J, Egede L, Retseck J, Banerjee A, Ehrlich V, Stolley M, Power S. Leveraging Social Determinants of Health to Reduce Hospital Length of Stay: A Pilot QI Project for Solid Tumor Oncology Patients During the COVID-19 Pandemic. WMJ. 2022 Oct;121(3):205-211. |
22. Conroy M, Powell M, Suelzer E, Pamulapati S, Min H, Wright T, Kamaraju S. Electronic Medical Record-Based Electronic Messaging Among Patients with Breast Cancer: A Systematic Review. Appl Clin Inform. 2023 Jan;14(1):134-143. PMCID: PMC9931493 |
23. Pamulapati S, Conroy M, Madireddy S, Kamaraju S, Cortina C, Moore H, Hartmann J. Applications of Viscoelastic Testing in Breast Cancer Patients: A Systematic Review Focusing on Hypercoagulability and Free Flap Thrombosis. Semin Thromb Hemost. 2024 Apr;50(3):413-422. |
24. Patel MI, Hinyard L, Hlubocky FJ, Merrill JK, Smith KT, Kamaraju S, Carrizosa D, Kalwar T, Fashoyin-Aje L, Gomez SL, Jeames S, Florez N, Kircher SM, Tap WD. Assessing the Needs of Those Who Serve the Underserved: A Qualitative Study among US Oncology Clinicians. Cancers (Basel). 2023 Jun 23;15(13). PMCID: PMC10341104 |
25. Chaudhary LN, Jorns J, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo M, Kong A, Patten C, Yen T, Cortina C, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H. Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy. Res Sq. 2023 Apr 07. PMCID: PMC10104267 |
26. Chervoneva I, Peck AR, Sun Y, Yi M, Udhane SS, Langenheim JF, Girondo MA, Jorns JM, Chaudhary LN, Kamaraju S, Bergom C, Flister MJ, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Palazzo JP, Bibbo M, Hyslop T, Nevalainen MT, Pestell RG, Fuchs SY, Mitchell EP, Rui H. High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer. JCO Precis Oncol. 2023 Jan;7:e2100498. PMCID: PMC9928763 |
27. Pamulapati S, Conroy M, Cortina C, Harding E, Kamaraju S. Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations. Arch Sex Behav. 2024 May;53(5):1969-1980. |
28. Pierro M, Zurko J, Szabo A, Cheng YC, Kamaraju S, Burfeind J, Retseck J, Chitambar CR, Chaudhary LN. Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection. WMJ. 2023 Dec;122(5):418-421. |
29. Chaudhary LN, Jorns J, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo M, Kong A, Patten C, Yen T, Cortina C, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H. Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy. Res Sq. 2023 Apr 07. PMCID: PMC10104267 |
30. Patel MI, Hinyard L, Merrill JK, Smith KT, Lei J, Carrizosa D, Kamaraju S, Hlubocky FJ, Kalwar T, Fashoyin-Aje L, Gomez SL, Jeames S, Florez N, Kircher SM, Tap WD. Challenges and Solutions to Support Oncology Professionals Serving Underserved Populations With Cancer in the United States: Results From the ASCO Serving the Underserved Task Force. JCO Oncol Pract. 2024 May;20(5):688-698. |
31. Kamaraju S, Canales B, Szabo A, Welter D, Beckius A, Wright T, Ehrlich V, Kothari A, Banerjee A, Stolley M, Power S. Addressing social determinants of health for oncology patients: can we reduce hospital readmissions? Annals of Cancer Epidemiology. Vol 8, April 30, 2024. |
32. Jorns JM, Sun Y, Kamaraju S, Cheng YC, Kong A, Yen T, Patten CR, Cortina CS, Chitambar CR, Rui H,Chaudhary LN.Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer J.Pers. Med 2024. 14 (5), 478; https://doi.org/10.3390/jpm14050478 |
33. Pamulapati S, Conroy M, Cortina CS, Harding E, Kamaraju S et al. Systematic Review on gender-affirming testosterone therapy and the risk of breast cancer: A challenge for physicians treating patients from transgender and gender-diverse populations. Arch Sex Behav. 2023 Dec 26. doi: 10.1007/s10508-023-02773-6
|
34. Kamaraju S; DeNomie M; Qureshi F; Tahir A; Sahr N; Phillips L; Harris C; Sehgal D; Banerjee A; Olson J.
Training the Trainees: A Multilingual Community Health Workers’ led Breast Health Project at Faith-based Centers in Milwaukee, WI.
International Journal of Cancer Care and Delivery
2023-10-18
DOI: 10.53876/001c.88482
|
35. Chervoneva I; Peck AR; Sun; Misung Yi; Udhane SS; Langenheim JF; Girondo MA; Jorns JM; Kamaraju S,Chaudhary LN. et al.
High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer
JCO Precision Oncology
2023-01 | Journal article
DOI: 10.1200/PO.21.00498 |
36. Conroy M, Kamaraju S, Powell M, Harris A, Beckius A, Nagavally S, Dawson A, Min H, Wright T, Wainaina N, Binder AF. Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging Among Patients With Breast Cancer: A Quality Improvement Study. Clin Breast Cancer. 2023 Oct;23(7):e434-e440. |
37. Kamaraju S, Conroy M, Harris A, Georgen M, Min H, Powell M, Kurzrock R. Challenges to genetic testing for germline mutations associated with breast cancer among African Americans. Cancer Treat Rev. 2024 Mar;124:102695. |
38. Lee AY, Lyons AT, Makris V, Kamaraju S, Stolley MR, Neuner JM, Flynn KE. Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women. Support Care Cancer. 2024 Apr 02;32(4):265. |
39. Kamaraju S, McKoy J, Williams GR, Gilmore N, Minami C, Bylow K, Rajalingam H, Cortina CS, Beckert A, Stolley M, Bullock D, Kurzrock R, Jatoi A. An Annual Symposium on Disparities in Milwaukee, WI, with a 2023 Focus on Older Adults with Cancer. Curr Oncol Rep. 2024 Aug;26(8):855-864. PMCID: PMC11300154 |
40. Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS. Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients. Ann Surg Oncol. 2024 Sep;31(9):5560-5569. PMCID: PMC11309885 |
41. Jorns JM, Sun Y, Kamaraju S, Cheng YC, Kong A, Yen T, Patten CR, Cortina CS, Chitambar CR, Rui H, Chaudhary LN. Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer. J Pers Med. 2024 Apr 29;14(5). PMCID: PMC11121947 |
42. Min H*, Weil E, Nelson M, Charlson J, ChengYC, Chaudhary LN, Burfeind J, Retseck J, Sriram D, Kamaraju S.. Improving measured health-related quality of life with outpatient high-dose methotrexate regimen among oncology patients with intracranial metastases: A systematic assessment Archives of Nursing Practice and Care. ISSN: 2581-4265. I supervised the first author, a medical student, during this project. |
43. Fang K, Ohihoin AG, Liu T, Choppavarapu L, Nosirov B, Wang Q, Yu XZ, Kamaraju S, Leone G, Jin VX. Integrated single-cell analysis reveals distinct epigenetic-regulated cancer cell states and a heterogeneity-guided core signature in tamoxifen-resistant breast cancer. Genome Med. 2024 Nov 18;16(1):134. PMCID: PMC11572372 |
44. Thareja SK, Yang X, Upama PB, Abdullah A, Torres SP, Cocroft LJ, Bubolz M, McGaughey K, Lou X, Kamaraju S, Ahamed SI, Madiraju P, Kwitek AE, Whittle J, Franco Z. Equitable community-based participatory research engagement with communities of color drives All of Us Wisconsin genomic research priorities. J Am Med Inform Assoc. 2024 Oct 23. |
Books, Chapters, and Reviews |
1. Brown SA, Beavers C, Kamaraju S, Mohan M, Fatunde O, Echefu G, Zaharova S, Wallace B, Oxencis C. Principles of Drug Metabolism and Interactions in Cardio-Oncology: Drug Interactions in Cardio-Oncology DRUG METABOLISM HANDBOOK: CONCEPTS AND APPLICATIONS IN CANCER RESEARCH. 1 January 2022:967-992. |
Non-Refereed Journal Publications/Original Papers |
1. Kamaraju, Sailaja, A Day at Mobile Hospital. Saradhi, Sanathana 2015 Sept (Journal for a private university hospital, Satya Sai Mobile Hospital, AP, India.) Saradhi, Sanathana. |
2. Kamaraju, Sailaja. Finding strength, convenience and coordination important when dealing with complexity of disease. Froedtert Today 05/09/2016. Froedtert Today. |
3. Kamaraju, Sailaja. After a cancer diagnosis: Seven questions to ask. Waukesha Freeman 2016 Oct:3B Waukesha Freeman. |
4. Kamaraju, Sailaja. Cancer Myths and Facts, Readers Digest 2017 Mar, http://www.rd.com/health/conditions/causes-of-cancer-myths/ Readers Digest. |
5. Kamaraju, Sailaja. After a cancer diagnosis: Seven questions to ask. Milwaukee Journal Sentinel 2017 July 24, www.jsonline.com/story/sponsor-story/froedtert/2017/07/24/after-a-cancer-diagnosis-7-questions-to-ask/103885628/ Milwaukee Journal Sentinel. |
Abstracts |
1. SABCS 2024: A011801 (CompassHER2 RD): Postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer. Post neoadjuvant T-DM1+ Tucatinib/Placebo in patients with Residual HER2-Positive invasive breast cancer. Ciara Sullivan, Karia Ballman, Linda McCall, Tyler Zmla, Anna Weiss, Melissa P Mitchell, Victoria S. Blinder, Nadine M. Tung, William J.Irvin Jr, Sailaja Kamaraju, Myounghee Lee, Matthew P. Goetz, W. Fraser Symmans, Virginia F. Borges, Ian Krop, Ann H. Partridge, Lisa A. Carey.
|
2. SABCS 2024: Quantitative changes in hormone receptor- and Ki67-levels in response to short-term neoadjuvant endocrine therapy in breast cancer. Rehaan K. Machhi, Yunguang Sun, Julie M. Jorns, Yee Chung Cheng, Sailaja Kamaraju, Mary Beth Gonyo, Amanda Kong, Caitlin Patten, Tina Yen, Chandler Cortina, Christopher R. Chitambar, Hallgeir Rui, and Lubna N. Chaudhary |
3. SABCS 2024: Evaluation and Management of Incomplete Ovarian Function Suppression in Premenopausal Breast Cancer Patients Receiving Anti-Hormone Therapy. Ruchi Patel, Elizabeth Weil, Sara Bugamelli, Emma Carroll, Kylie Steinke, Erinn Stockhausen, Yee Chung Cheng, John Burfeind, Lubna Chaudhary, Sailaja Kamaraju, Colin Mooney, Janet Retseck, eepika Sriram, MD, Jutta Deininger, Angela Halbach, Maressa Sweeney (#1095).
|
4. Istl AC, Lawton S, Kamaraju S, Stolley M, Petroll AE, Cortina CS. ASO Visual Abstract: Tumors, Treatments, and Trust: Cancer Characteristics, Outcomes, and Screening Uptake in Transgender and Gender-Diverse Patients. Ann Surg Oncol. 2024 Sep;31(9):5591-5592. |
5. SABCS 2024: Overall Survival Results of Bria-IMT Allogenic Whole Cell-Based Cancer Vaccine. Saranya Chumsri, Sailaja Kamaraju, Blaise Bayer, Minglin Chang, Tamar Aghajanian, William Williams, Charles Wiseman, Giuseppe Del Priore. |
6. SABCS 2024: ASTRO-VAC CNS: Bria-IMT in the Management of Metastatic CNS Lesions. Sailaja Kamaraju; Blaise Bayer; Mingjin Chang; William Williams; Charles Wiseman; Giuseppe Del Priore. (#1068) |
7. SABCS 2024: Survival Outcomes of Transgender and Gender-Diverse Patients with Breast Cancer from 2004–2022 in the National Cancer Database. Kelley Chan MD, MS; Joseph H Cotler PhD; Alexandra Istl MD, MPH; Andrew E Petroll MD, MS; Sailaja Kamaraju, MD, MS; Melinda Stolley, PhD; Chandler S Cortina MD, MS |
8. AACR 2024. Abstract ID: CT 204 (4/9/2024). Efficacy of Bria-IMT regimen in inducing CNS metastasis regression. Sailaja Kamaraju, Blaise Bayer, Minglin Chang, Tamar Aghajanian, William Williams, Charles Wiseman, Giuseppe Del Priore. Cancer Res (2024) 84 (7_Supplement): CT204. |
9. ASCO 2024: Sailaja Kamaraju, Saranya Chumsri, Blaise Bayer, Mingjin Chang, William Williams, Charles L. Wiseman, Giuseppe Del Priore.
Differential efficacy of SV-BR-1-GM in inducing intracranial metastasis regression. |
10. ASCO 2024: Tumors, treatments, and trust: Cancer characteristics, outcomes and screening uptake in transgender and gender-diverse patients. Ann Surg Oncol. June 2024. doi: 10.1245/s10434-024-15483-7. Online ahead of print. PMID: 38864983 |
11. SABCS 2023: PS18-04. Spotlight poster on 12/8/2023 Racial Disparities in Breast Cancer and Effect of Obesity: MammaPrint®, BluePrint® and Whole Transcriptome Analyses of Tumors in Latin American Patients in FLEX Trial. Marcela Mazo Canola1, Virginia Kaklamani1, Pooja P. Advani2, Sailaja Kamaraju3, Alfredo A. Santillan-Gomez4, Robert Maganini5, Julie L. Barone6, Sahra Uygun7, Lavanya Samraj7, William Audeh7, Joyce O'Shaughnessy8, FLEX Investigators Group |
12. SABCS 2023: P02-17-05 Pharmacy fills but not baseline distress or other clinical factors can identify those at high risk for early adjuvant endocrine therapy discontinuation. Joan Neuner, Rodney Sparapani, Jabob Tiegs, Vala Makris, Mlinda Stolley, Sailaja Kamaraju, Bradley Crotty, Kathryn Flynn. |
13. ASCO 2023 Abstract 422384: A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer. Authors: Nan Chen, Poornima Saha, Murtuza M. Rampurwala, Sailaja Kamaraju, Olwen Mary Hahn, Frederick Matthew Howard, Gini F. Fleming, Margarite Matossian, Jincong Q. Freeman, Theodore Karrison, Suzanne D. Conzen, Rita Nanda, Erica Michelle Stringer-Reasor; University of Chicago, Chicago, IL; NorthShore University HealthSystem, Evanston, IL; Froedtert & Medical College of Wisconsin, Milwaukee, WI; University of Chicago Medical Center, Chicago, IL; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL; Department of Public Health Sciences, The University of Chicago, Chicago, IL; UT Southwestern Medical Center, Dallas, TX; University of Alabama at Birmingham, Birmingham, AL
|
14. ASCO 2023 Abstract 416518: Impact of neighborhood disadvantage on stage at diagnosis and outcomes in women diagnosed with breast cancer. Authors: Alexandra A Harris, Aniko Szabo, Sailaja Kamaraju, Yee Chung Cheng, John D. Burfeind, Christopher R. Chitambar, Lubna Naaz Chaudhary; Froedtert & Medical College of Wisconsin, Milwaukee, WI; Division of Biostatistics, Froedtert and The Medical College of Wisconsin, Milwaukee, WI
|
15. ASCO 2023: Nan Chen, Poornima Saha, Murtuza M. Rampurwala, Sailaja Kamaraju, Olwen Mary Hahn, Frederick Matthew Howard, Gini F. Fleming, Margarite Matossian, Jincong Q. Freeman, Theodore Karrison, Suzanne D. Conzen, Rita Nanda, Erica Michelle Stringer-Reasor.
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer. |
16. SABCS 2023- PO3-18-11. Alliance A011801 (CompassHER2 RD): Post neoadjuvant T-DM1+ Tucatinib/Placebo in patients with Residual HER2-Positive invasive breast cancer. Ciara Sullivan, Karia Ballman, Linda McCall, Tyler Zmla, Anna Weiss, Melissa P Mitchell, Victoria S. Blinder, Nadine M. Tung, William J.Irvin Jr, Sailaja Kamaraju, Myounghee Lee, Matthew P. Goetz, W. Fraser Symmans, Virginia F. Borges, Ian Krop, Ann H. Partridge, Lisa A. Carey. |
17. SABCS 2022. Abstract P4-01-19: Real World Statistics on CDK4/6 Inhibitor Use in Metastatic Hormone Receptor Positive and HER2-Negative Breast Cancer with a Focus on Age. Kathleen Monahan; Sailaja Kamaraju; Yee Chung Cheng; Janet Retseck; Deepika Sriram; John Burfeind; Christopher Chitambar; Lubna N. Chaudhary. Cancer Res (2023) 83 (5_Supplement): P4-01-19. |
18. SABCS 2022: PO3-13-05PD-L1 and PD-L2 Protein Expression is Frequently Discordant in Breast cancer- Lubna N. Chaudhary, Julie M Jorns, Yunguang Sun, Sailaja Kamaraju, Yee Chung Cheng, Amanda Kong, Tina W.F. Yen, Caitlin Patten, Chandler Cortina, Inna Chervoneva, Christopher Chitambar, Hallgeir Rui. |
19. SABCS 2022: Abstract P5-14-15: Examining inequities related to inpatient hospital length of stay for breast cancer patients: A retrospective study during the COVID-19 pandemic. Sailaja Kamaraju; Bethany Canales; Tamiah Wright; John Charlson; Aniko Szabo; Thomas Wetzel; Steve Power; Grace Campbell. Cancer Res (2022) 82 (4_Supplement): P5-14-15. |
20. SABCS 2022: Abstract OT2-16-01: The SMILE study: A phase 2 trial of onapristone in combination with fulvestrant for patients with ER+ and HER2- metastatic breast cancer after progression on endocrine therapy and CDK4/6 inhibitors, 2/15/2022. Cancer Res (2022) 82 (4_Supplement): OT2-16-01. Sailaja Kamaraju; Amy Fowler; Chung Yee Cheng; Lubna N Chaudhary; John Burfeind; Janet Retseck; Amye J Tevaarwerk; Mark Burkard; Elisavet Paplomata; Amanda M Parkes; Julie M Jorns; Sergey Tarima; Douglas Yee; Hallgeir Rui; Carol Lange; Tarek Sahmoud; Kari B Wisinski. |
21. SABCS 2022: Abstract P4-02-03: HER1-4 protein up-regulation following short-term neoadjuvant endocrine therapy in patients with hormone receptor-positive HER2-negative breast cancer. Lubna Naaz Chaudhary; Julie M Jorns; Yee Chung Cheng; Sailaja Kamaraju; John Burfeind; Mary Beth Gonyo; Amanda Kong; Caitlin Patten; Tina Yen; Chandler Cortina; Ebony Carson; Nedra Johnson; Carmen Bergom; Anjishnu Banerjee; Yu Wang; Yunguang Sun; Christopher R Chitambar; Hallgeir Rui. Cancer Res (2022) 82 (4_Supplement): P4-02-03. |
22. SABCS 2022: Abstract P5-14-15: Examining inequities related to inpatient hospital length of stay for breast cancer patients: A retrospective study during the COVID-19 pandemic Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John Charlson, Aniko Szabo, Thomas Wetzel, Steve Power, Grace Campbell. Cancer Res (2022) 82 (4_Supplement): P5-14-15.
https://doi.org/10.1158/1538-7445.SABCS21-P5-14-15.
|
23. American College of Cardiology 2022: AC Rachel E. Goodman, Sarah Elizabeth Thordsen, Nithya Sridhar, Anna Calderon, Elizabeth Weil, Lubna N. Chaudhary, Sailiaja Kamaraju, Janet Retseck, John Charlson, John Burfeind, Christopher R. Chitambar, Yee Chung Cheng, Sherry-Ann Brown. Change In Left Ventricular End Diastolic Index Or Global Longitudinal Strain May Predict Development Of Cancer Therapy Related Cardiac Dysfunction In Her2 Positive Breast Cancer Patients Receiving Trastuzumab. Journal of Am Coll Cardiol. 2022 Mar, 79 (_Supplement) 1887. |
24. ASCO 2021 Joanna Zurko, Aniko Szabo, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind, Janet Retseck, Christopher R. Chitambar, Lubna Naaz Chaudhary.
Matched case control analysis of breast cancer specific factors impacting risk of developing SARS-Cov-2 infection. |
25. ASCO 2021: Examining patient specific factors associated with inpatient hospital length of stay for solid tumor oncology patients from low socioeconomic communities in Milwaukee, WI. Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John Charlson, Aniko Szabo, Donggwan Lee, Thomas Wetzel, Kevin Richardson, Kathleen Jensik, Steve Power, and Grace Campbell. (#232) |
26. SABCS 2017: Abstract PD4-07: Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population study. S Kamaraju; E Smith; Y Shi; P Laud; J Neuner. Cancer Res (2017) 77 (4_Supplement): PD4-07). |
27. Schorer AE, Kubic VL, Kamaraju S. Cytogenetic abnormalities in patients with known or suspected multiple myeloma Blood. 2000;96(11 PART II). |
28. Academic Surgical Congress: 2024: Are There Racial and Ethnic Disparities in Who Receives Neoadjuvant Chemotherapy for Early-Stage HER2-Positive Breast Cancer? Lauren Cohen, Christine Rogers, Jan IC Lloren,
Sailja Kamaraju, Lubna N Chaudhary, Chiang-Ching Huang, Mediget Teshome, Puneet Singh, Adrienne N Cobb, Amanda L Kong, Chandler S Cortina. |
